Botulinum toxin type A in the treatment of children and adolescents with an acquired brain injury

Brain Injury

Volumn 19, Issue 5, 2005, Pages 331-335

  van Rhijn, Johanna ^a   Molenaers, G ^b   Ceulemans, B ^a,c  

^a Rehabilitation Centre for Children and Youth   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Botulinum toxin type A BTX A; Brain injury; Children; Spasticity

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG SAFETY; FEMALE; GONIOMETRY; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SPASTIC PARAPLEGIA; SPASTIC PARESIS; SPASTICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 20444382775     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050400013675     Document Type: Article

References (18)

1. Gormley ME Jr, O'Brien CF, Yablon SA. A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve Suppl 1997;6:S14-20.
2. Lance J. Pathophysiology of spasticity and clinical experience with baclofen. In: Feldman R, Young R, Koella W, editors. Spasticity: Disordered Motor Control. Chicago, IL: Year Book Medical Publishers; 1980. pp. 185-203.
3. Gracies JM, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity: Part I: Local treatments. Muscle Nerve Suppl 1997;6:S61-91.
4. Gracies JM, Nance P, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity: Part II: General and regional treatments. Muscle Nerve Suppl 1997;6:S92-121.
5. Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl 1997;6:S169-75.
6. Gudex CM, Hawthorne MR, Butler AG, Duffey P. Effect of dystonia and botulinum toxin treatment on health-Related quality of life. Movement Disorders 1998;13:941-6.
7. Molenaers G, Desloovere K, Eyssen M, De Cat J, Jonkers I, De Cock P. Botulinum toxin Type A treatment of cerebral palsy: An integrated approach. European Journal of Neurology 1999;6(suppl 4):S51-7.
8. Van Kuijk A, Geurts A, Bevaart B, Van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuron or neuromuscular blockade: A systematic review of literature. Journal of Rehabilitation Medicine 2002;34:51-61.
9. Boyd R, Morris M, Graham H. Management of upper limb dysfunction in children with cerebral palsy: A systematic review. European Journal of Neurology 2001;8(Suppl 5):150-66.
10. Fehlings D, Rang M, Glazier J. Botulinum toxin type A injections in the spastic upper extremity of child with hemiplegia: Child characteristics that predict a positive outcome. European Journal of Neurology 2001;8(Suppl 5): 145-9.
11. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Developmental Medicine and Child Neurology 1994;36:386-96.
12. Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: An open-labeled trial. Neurology 1996;47:939-44.
13. Autti-Ramo I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: Clinical implications. European Journal of Neurology 2001;8(Suppl 5):S136-44.
14. Brashear A, Gordon M, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox Post Stroke Spasticity Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. New England Journal of Medicine 2002;347:395-400.
15. Brashear A, McAfee AL, Kuhn ER, Fyffe J. Botulinum toxin type B in upper limb poststroke spasticity: A double-blind, placebo-controlled trial. Archives of Physical Medicine and Rehabilitation 2004;85:705-9.
16. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic foot drop. Journal of Neurology 1992;239:375-8.
17. Molenaers G, Desloovere K, Jonkers I, Glorieux F, De Cock P. The effect of multilevel botulinum toxin type A treatment combined with short leg casting and orthotic management on the gait of CP children. Gait Posture 1999;10:74.
18. Burbaud P, Wiart L. Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A. A randomised, double-blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. Journal of Neurology, Neurosurgery and Psychiatry 1996;61:265-9.